Dr Perla Joyce Andin, MD | |
905 Little Britain Rd, New Windsor, NY 12553-5522 | |
(845) 564-7066 | |
(845) 549-1044 |
Full Name | Dr Perla Joyce Andin |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 34 Years |
Location | 905 Little Britain Rd, New Windsor, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023013059 | NPI | - | NPPES |
A400046509 | Other | MEDICARE | |
01988861 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 213494 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Willcare Chha (newburgh) | Newburgh, NY | Home health agency |
Evercare At Home | Newburgh, NY | Home health agency |
Archcare At Home | Valhalla, NY | Home health agency |
Hospice Of Orange & Sullivan Counties Inc | Newburgh, NY | Hospice |
St Luke's Cornwall Hospital | Newburgh, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Horizon Medical Group Pc | 6103715529 | 66 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.
Molecular Targeting Technologies, Inc., announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.
With questions emerging about the handling of Ebola patients, a House subcommittee is holding a hearing that will feature testimony from CDC Director Tom Frieden and Dr. Daniel Varga, chief clinical officer and senior executive vice president at Texas Health Presbyterian Hospital.
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.
Kaiser Health News provides a fresh take on health policy developments with "Fear Itself" by Steve Kelley.
› Verified 9 days ago
Entity Name | Horizon Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063488179 PECOS PAC ID: 6103715529 Enrollment ID: O20040313000206 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.
Molecular Targeting Technologies, Inc., announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.
With questions emerging about the handling of Ebola patients, a House subcommittee is holding a hearing that will feature testimony from CDC Director Tom Frieden and Dr. Daniel Varga, chief clinical officer and senior executive vice president at Texas Health Presbyterian Hospital.
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.
Kaiser Health News provides a fresh take on health policy developments with "Fear Itself" by Steve Kelley.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Perla Joyce Andin, MD 2 Coates Dr, Goshen, NY 10924-6758 Ph: (845) 651-1400 | Dr Perla Joyce Andin, MD 905 Little Britain Rd, New Windsor, NY 12553-5522 Ph: (845) 564-7066 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.
Molecular Targeting Technologies, Inc., announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.
With questions emerging about the handling of Ebola patients, a House subcommittee is holding a hearing that will feature testimony from CDC Director Tom Frieden and Dr. Daniel Varga, chief clinical officer and senior executive vice president at Texas Health Presbyterian Hospital.
Researchers at the University of Waterloo have developed a new way to prevent and treat Chlamydia, the most common sexually transmitted bacterial infection in the world.
Kaiser Health News provides a fresh take on health policy developments with "Fear Itself" by Steve Kelley.
› Verified 9 days ago
Frederick C Beckett Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 484 Temple Hill Rd, Suite 104, New Windsor, NY 12553 Phone: 845-565-3700 | |
Dr. Joseph George, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 575 Hudson Valley Ave, Ste 200, New Windsor, NY 12553 Phone: 845-561-2773 Fax: 914-593-7881 | |
Anne R. Mullin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3068 Route 9w Ste 200, New Windsor, NY 12553 Phone: 845-534-9590 Fax: 845-534-9685 | |
Mahavir Singh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3074 9 W South, New Windsor, NY 12553 Phone: 845-561-8902 Fax: 845-561-8910 | |
Arif M Muslim, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 955 Little Britain Rd, New Windsor, NY 12553 Phone: 845-562-0740 | |
Dr. Stuart Liederson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3121 Route 9w, Suite 104, New Windsor, NY 12553 Phone: 845-562-2272 Fax: 845-562-1973 |